Fig. 2From: A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinomaThe prognostic signature based on 10 immune-related genes in LUAD. a The distribution and survival status of patients for the immune-related gene signature. b Time-dependent ROC results at 1, 3, and 5 years. c Kaplan–Meier curves between the high-risk and low-risk groupsBack to article page